Search
for

    Glossary Tamoxifen

    medication used to treat and prevent breast cancer

    Tamoxifen, also known by brand names like Nolvadex and Soltamox, is a medication primarily used to treat and prevent breast cancer. It works by binding to estrogen receptors, thereby blocking the effects of estrogen on breast tissue, which can slow or stop the growth of hormone receptor-positive breast cancer cells.

    Related Terms

    Sort by

    Research 30 of 792

    1. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16. Journal of Clinical Oncology · 1990 · 279 citations
    2. Tamoxifen for flutamide/finasteride-induced gynecomastia Urology · 1997 · 49 citations
    3. Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study British Journal of Dermatology · 2013 · 24 citations
    4. Clinical Case Notes. Tamoxifen optic neuropathy Clinical and Experimental Ophthalmology · 2004 · 23 citations
    5. Tamoxifen-Induced Total Alopecia Annals of Internal Medicine · 2001 · 19 citations
    6. Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography British Journal of Dermatology · 2012 · 16 citations
    7. Tamoxifen-Induced Female Androgenetic Alopecia in a Patient with Breast Cancer Annals of Internal Medicine · 1997 · 15 citations
    8. Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients Journal of the European Academy of Dermatology and Venereology · 2015 · 8 citations
    9. Female pattern hair loss possibly caused by tamoxifen: Androgen receptor expression in the outer root sheath in the affected area Journal of Dermatology · 2012 · 5 citations
    10. Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines PloS one · 2024
    11. Nutraceuticals Known To Promote Hair Growth Do Not Interfere With The Inhibitory Action of Tamoxifen In MCF7, T47D And BT483 Breast Cancer Cell Lines Research Square (Research Square) · 2022
    12. Nutraceuticals Known to Promote Hair Growth Do not Interfere with the Inhibitory Action of Tamoxifen in MCF7, T47D and BT483 Breast Cancer Cell Lines Research Square (Research Square) · 2021
    13. LB822 Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in breast cancer cells 2021
    14. Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome 2015
    15. The Effects of Estradiol, Androgens and the Selective Estrogen Modulators: Ospemifene, Raloxifene and Tamoxifen on Explant Cultures of Human Breast Tissue UTUPub (University of Turku) · 2013
    16. Effects of cyproterone and tamoxifen upon the hair waves in mice. PubMed · 1982
    17. Tamoxifen-induced androgenetic alopecia in a dialysis patient with sclerosing encapsulating peritonitis (SEP) Indian Journal of Nephrology · 2004
    18. Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen Journal of Personalized Medicine · 2026
    19. Treatment options for polycystic ovary syndrome International journal of women's health · 2011 · 514 citations
    20. Hair Follicle Dermal Stem Cells Regenerate the Dermal Sheath, Repopulate the Dermal Papilla, and Modulate Hair Type Developmental Cell · 2014 · 184 citations
    21. YAP and TAZ are essential for basal and squamous cell carcinoma initiation EMBO Reports · 2018 · 76 citations
    22. Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer JAMA Dermatology · 2018 · 67 citations
    23. Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents Annals of Oncology · 2005 · 67 citations
    24. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013 · 48 citations
    25. Differential sensitivity of epidermal cell subpopulations to β-catenin-induced ectopic hair follicle formation Developmental Biology · 2010 · 43 citations
    26. Genetic Fate Mapping Using Site-Specific Recombinases Methods in Enzymology · 2010 · 29 citations
    27. Metabolic and pathologic profiles of human LSS deficiency recapitulated in mice PLOS genetics · 2020 · 23 citations
    28. Clinical Case Notes. Intraorbital ophthalmic artery aneurysms Clinical and Experimental Ophthalmology · 2004 · 20 citations
    29. Injury modifies the fate of hair follicle dermal stem cell progeny in a hair cycle‐dependent manner Experimental dermatology · 2019 · 16 citations
    30. Clinical Case Notes. Lipoid proteinosis: a rare disorder with pathognomonic lid lesions Clinical and Experimental Ophthalmology · 2004 · 13 citations